Matches in Nanopublications for { ?s ?p "[In contrast to endometrioid carcinomas, serous cancers expressed substantially lower levels of DNMT1 and DNMT3B than normal controls, with four- and twofold reduction observed in DNMT1 and DNMT3B mRNA levels, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP801995.RAckzP7KKLi2Gi6hPIv8cN9Ua4DiuP1CNMUKKL5w5Rh7Q130_assertion description "[In contrast to endometrioid carcinomas, serous cancers expressed substantially lower levels of DNMT1 and DNMT3B than normal controls, with four- and twofold reduction observed in DNMT1 and DNMT3B mRNA levels, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP801995.RAckzP7KKLi2Gi6hPIv8cN9Ua4DiuP1CNMUKKL5w5Rh7Q130_provenance.
- assertion description "[In contrast to endometrioid carcinomas, serous cancers expressed substantially lower levels of DNMT1 and DNMT3B than normal controls, with four- and twofold reduction observed in DNMT1 and DNMT3B mRNA levels, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP357425.RATR7NnNkzBrQalK4XD33yE8MLxKklva3Zc2zx_FYtUqI130_assertion description "[In contrast to endometrioid carcinomas, serous cancers expressed substantially lower levels of DNMT1 and DNMT3B than normal controls, with four- and twofold reduction observed in DNMT1 and DNMT3B mRNA levels, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP357425.RATR7NnNkzBrQalK4XD33yE8MLxKklva3Zc2zx_FYtUqI130_provenance.
- NP358001.RATfLCS2jn81gK27ODayAi5ZHxfDyd2ulEB2bcfbqqtc4130_assertion description "[In contrast to endometrioid carcinomas, serous cancers expressed substantially lower levels of DNMT1 and DNMT3B than normal controls, with four- and twofold reduction observed in DNMT1 and DNMT3B mRNA levels, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP358001.RATfLCS2jn81gK27ODayAi5ZHxfDyd2ulEB2bcfbqqtc4130_provenance.
- NP761646.RA9xOUg9cdUTBIrS1gv185TwrlApLMisMvGtAzxuNYcr8130_assertion description "[In contrast to endometrioid carcinomas, serous cancers expressed substantially lower levels of DNMT1 and DNMT3B than normal controls, with four- and twofold reduction observed in DNMT1 and DNMT3B mRNA levels, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761646.RA9xOUg9cdUTBIrS1gv185TwrlApLMisMvGtAzxuNYcr8130_provenance.
- NP481619.RAaoZGypD49DmI780D0LzbteYfa_12t9hD3yH6varvb5M130_assertion description "[In contrast to endometrioid carcinomas, serous cancers expressed substantially lower levels of DNMT1 and DNMT3B than normal controls, with four- and twofold reduction observed in DNMT1 and DNMT3B mRNA levels, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP481619.RAaoZGypD49DmI780D0LzbteYfa_12t9hD3yH6varvb5M130_provenance.
- NP481620.RAVt1EjeHW1jTeTRZ8ThsuabgxZK4ugIr0KWAXcVfKhag130_assertion description "[In contrast to endometrioid carcinomas, serous cancers expressed substantially lower levels of DNMT1 and DNMT3B than normal controls, with four- and twofold reduction observed in DNMT1 and DNMT3B mRNA levels, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP481620.RAVt1EjeHW1jTeTRZ8ThsuabgxZK4ugIr0KWAXcVfKhag130_provenance.